Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Fundamental issue

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon Oct 01, 2022 8:05am

127 Views

Post# 34999140

RE:RE:Fundamental issue

Seems like only Geraldine contribute with value among management. Unfortunately, I think she's good as long she can continue with lab magics.

But what if she'd realize that the business is at risk? Would be great if someone has an established communication with her in position to reach out.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments